On July 15, 2024, GSK plc reported the acquisition of shares by its executives, including 7,033 shares at £15.0500 each, resulting from reinvested dividends announced on July 11, 2024. This filing outlines transactions by various executive directors and is classified under changes in management or control. The sentiment is neutral, and it is considered significant.